| 1990 - 268 lapas
...provided in §§ 6O1.6 to 601.8 with respect to the suspension and the revocation of licenses. [42 PR 4718, Jan. 25, 1977] § 601.25 Review procedures to...products from the provisions of the Federal Food, Drug, and Cosmetic Act is superseded to the extent that these regulations result in imposing requirements... | |
| 2005 - 210 lapas
...licenses. [42 FR 4718, Jan. 25, 1977, as amended at 61 FR 24233, May 14, 1996; 64 FR 56452, Oct. 20, 1999] §601.25 Review procedures to determine that licensed...products from the provisions of the Federal Food, Drug, and Cosmetic Act is superseded to the extent that these regulations result in imposing requirements... | |
| 2002 - 216 lapas
...licenses. [42 FR 4718, Jan. 25, 1977, as amended at 61 FR 24233, May 14, 1996; 64 FR 56452. Oct. 20, 1999] §601.25 Review procedures to determine that licensed...products from the provisions of the Federal Food, Drug, and Cosmetic Act is superseded to the extent that these regulations result in imposing requirements... | |
| 2000 - 206 lapas
...FR 4718, Jan. 25, 1977, as amended at 61 FR 24233, May 14, 1996; 64 FR 56452, Oct. 20, 1999] $601.25 Review procedures to determine that licensed biological...products from the provisions of the Federal Food, Drug, and Cosmetic Act is superseded to the extent that these regulations result in imposing requirements... | |
| 1977 - 334 lapas
...provided in §§ 601.6 to 601.8 with respect to the suspension and the revocation of licenses. [42 FB 4718, Jan. 25, 1977] § 601.25 Review procedures to...misbranded under prescribed, recommended, or suggested condition* of use. For purposes of reviewing biological products that have been licensed prior to July... | |
| 1999 - 204 lapas
...development. 601.22 Products in short supply; initial manufacturing at other than licensed establishment. 601.25 Review procedures to determine that licensed...prescribed, recommended, or suggested conditions of use. 601.26 Reclassification procedures to determine that licensed biological products are safe, effective,... | |
| 1975 - 258 lapas
...601.40, 601.42, and 601.43 with respect to the summary suspension and the revocation of licenses. § 601.25 Review procedures to determine that licensed...safe, effective, and not misbranded under prescribed^ _recommended, or suggested condition* of use. For purposes of reviewing biological products that have... | |
| 1994 - 252 lapas
...development. 601.22 Products in short supply; initial manufacturing at other than licensed establishment. 601.25 Review procedures to determine that licensed biological products are safe, effective, and not mlsbranded under prescribed, recommended, or suggested conditions of use. 601.26 Reclassification procedures... | |
| 1973 - 318 lapas
...273.234, and 273.235 with respect to the summary suspension and the revocation of licenses. § 273.245 Review procedures to determine that licensed biological...products from the provisions of the Federal Food, Drug, and Cosmetic Act is superseded to the extent that these regulations result in imposing requirements... | |
| |